Market Place
Market Place
Post Enquiry
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
Novartis leads in new drug approvals; Vertex’s cystic fibrosis med holds highest sales potential
The US Food and Drug Administration’s (FDA) momentum of new drug approvals dropped marginally
